Limbix Health, Inc.
8
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
25.0%
2 terminated/withdrawn out of 8 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
80%
4 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
Role: collaborator
Virtual Reality Guided Imagery for Chronic Pain
Role: collaborator
Self-guided Treatment for Adolescents Navigating Depression
Role: lead
Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management
Role: lead
Digital Therapeutic for Adolescent Depressive Symptoms in Cardiology and Gastroenterology
Role: lead
A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19
Role: lead
A Mobile and Virtual Reality Intervention for Adolescent Depression
Role: lead
Building Evidence-Based Supports for Teens Via Technology
Role: collaborator
All 8 trials loaded